0001192482-20-000713.txt : 20200928
0001192482-20-000713.hdr.sgml : 20200928
20200928174959
ACCESSION NUMBER: 0001192482-20-000713
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200924
FILED AS OF DATE: 20200928
DATE AS OF CHANGE: 20200928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Balice-Gordon Rita J.
CENTRAL INDEX KEY: 0001825625
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 201205479
MAIL ADDRESS:
STREET 1: C/O COLLEGIUM PHARMACEUTICAL, INC.
STREET 2: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-09-24
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001825625
Balice-Gordon Rita J.
C/O COLLEGIUM PHARMACEUTICAL, INC.
100 TECHNOLOGY CENTER DRIVE
STOUGHTON
MA
02072
1
0
0
0
Common Stock
2020-09-24
4
A
0
5027
0
A
5027
D
Stock Option (Right to Purchase)
17.77
2020-09-24
4
A
0
10055
0
A
2030-09-24
Common Stock
10055
10055
D
Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on September 24, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.
The option vests and becomes exercisable on September 24, 2021, subject to the director's continued service with the issuer.
/s/ Paul Brannelly as Attorney-in-Fact for Rita J. Balice-Gordon
2020-09-28